Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Animal Model Development Workshop (Day 1)

Loading video...

516 Views  
Chapter Description Position
1 Thumbnail image Introduction and Overview - Judy Hewitt, NIAID 0:00:04
2 Thumbnail image Common themes: Animal Models for CBRN Countermeasures - George Korch, ASPR/HHS 0:19:32
3 Thumbnail image Bridging animal and clinical data - Lisa Hensley, MCMi/FDA 0:51:38
4 Thumbnail image Experience with rare clinical diseases - Simon Mardell (UK) 1:17:18
5 Thumbnail image Product Development Under the “Animal Rule” - Rosemary Roberts CDER/ FDA 2:07:56
6 Thumbnail image Model Qualification as a voluntary, product independent, mechanism - Jerry Davis, CDER/FDA 2:42:15
7 Thumbnail image Interagency Coordination of Animal Model Development and Qualification - Phil Ferro, ASPR/HHS 3:09:51
8 Thumbnail image Consistent euthanasia criteria - Estella Jones D.V.M. 3:32:06
9 Thumbnail image Supportive care overview: blending supportive care considerations with experimental design - Jim Swearengen , NBACC/DHS 4:02:33
10 Thumbnail image Supportive care case Studies: Ebola - Mark Kortepeter (USUHS) 4:39:26
11 Thumbnail image Supportive care case Studies: Rad/Nuc - Tom MacVittie (U of MD) 5:10:50
12 Thumbnail image Open Discussion 5:42:11
   
Air date: Monday, September 17, 2012, 8:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 516, (188 Live, 328 On-demand)
Category: Conferences
Runtime: 06:04:30
Description: The Animal Model Development Workshop will explore the scientific and regulatory challenges of developing medical countermeasures (MCM) under the FDA "Animal Rule” (21 CFR 314.600 for drugs; 21 CFR 601.90 for biological products). The goals of this workshop are to highlight the significant progress made in animal model development for MCMs, review recent case studies of products under development using animal models, and capture lessons learned to inform future animal model development efforts. In addition, the workshop will provide a forum to discuss current challenges and identify potential solutions or mitigation strategies.

For more information go to https://respond.niaid.nih.gov/conferences/AMDW/Pages/default.aspx
Debug: Show Debug
NLM Title: Animal Model Development Workshop [electronic resource] / NIAID, FDA, BARDA, TMT, DTRA.
Author: Animal Model Development Workshop
Publisher:
Abstract: (CIT): The Animal Model Development Workshop will explore the scientific and regulatory challenges of developing medical countermeasures (MCM) under the FDA "Animal Rule" (21 CFR 314.600 for drugs; 21 CFR 601.90 for biological products). The goals of this workshop are to highlight the significant progress made in animal model development for MCMs, review recent case studies of products under development using animal models, and capture lessons learned to inform future animal model development efforts. In addition, the workshop will provide a forum to discuss current challenges and identify potential solutions or mitigation strategies.
Subjects: Models, Animal
Publication Types: Congresses
Webcasts
Download: To download this event, select one of the available bitrates:
[256k]  [512k]    How to download a Videocast
Caption Text: Download Caption File
NLM Classification: QY 58
NLM ID: 101595140
CIT Live ID: 11813
Permanent link: http://videocast.nih.gov/launch.asp?17564